(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling

[1]  F. Levy,et al.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  A. Kaumann.  Gs protein-coupled receptors in human heart , 2000 .

[3]  T. McIntosh,et al.  The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. , 1998, The Journal of clinical investigation.

[4]  E. Kranias,et al.  Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline. , 1985, The Biochemical journal.

[5]  T. McIntosh,et al.  The Ile 164 b 2-Adrenergic Receptor Polymorphism Adversely Affects the Outcome of Congestive Heart Failure , 1998 .

[6]  Johannes H G M van Beek,et al.  Glycolytic buffering affects cardiac bioenergetic signaling and contractile reserve similar to creatine kinase. , 2003, American journal of physiology. Heart and circulatory physiology.

[7]  J. Arch,et al.  Effects of (−)‐RO363 at human atrial β‐adrenoceptor subtypes, the human cloned β3‐adrenoceptor and rodent intestinal β3‐adrenoceptors , 1997 .

[8]  T. Kenakin,et al.  The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems , 2012, Handbook of Experimental Pharmacology.

[9]  S. Liggett,et al.  beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. , 2000, American heart journal.

[10]  E. Lakatta,et al.  beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. , 1999, Circulation.

[11]  J. Port,et al.  Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. , 1989, Molecular pharmacology.

[12]  E. Kranias,et al.  Phospholamban: a prominent regulator of myocardial contractility. , 1996, Circulation research.

[13]  A. Kaumann,et al.  The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. , 1985, Naunyn-Schmiedeberg's archives of pharmacology.

[14]  E. Lakatta,et al.  Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. , 1999, Circulation research.

[15]  P. J. England,et al.  Studies on the phosphorylation of the inhibitory subunit of troponin during modification of contraction in perfused rat heart. , 1976, The Biochemical journal.

[16]  P. Karczewski,et al.  Activation of (cid:98) 2 -Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure , 1998 .

[17]  P. Molenaar,et al.  Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. , 2006, Cardiovascular research.

[18]  L. Heilmeyer,et al.  Stepwise subunit interaction changes by mono- and bisphosphorylation of cardiac troponin I. , 1998, Biochemistry.

[19]  S. Harding,et al.  The effect of pertussis toxin on β‐adrenoceptor responses in isolated cardiac myocytes from noradrenaline‐treated guinea‐pigs and patients with cardiac failure , 1992, British journal of pharmacology.

[20]  E. Kranias.  Regulation of Ca2+ transport by cyclic 3',5'-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulum. , 1985, Biochimica et biophysica acta.

[21]  P. Karczewski,et al.  Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts , 2004, Molecular and Cellular Biochemistry.

[22]  J. Wikberg,et al.  The effect of pertussis toxin on alpha-2-adrenoceptor-mediated pigment migration in fish melanophores. , 1985, Life sciences.

[23]  P. Karczewski,et al.  Both &bgr;2- and &bgr;1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of &bgr;2-Adrenergic Receptors to Gs-Protein , 2000 .

[24]  Hook Eb,et al.  Abortions because of unavailability of prenatal diagnosis. , 1981 .

[25]  M. Brown,et al.  Selective j31-Adrenoceptor Blockade Enhances Positive Inotropic Responses toEndogenous Catecholamines Mediated Through j2-Adrenoceptors inHumanAtrial Myocardium , 1990 .

[26]  S. Kakiuchi,et al.  Effects of phospholamban phosphorylation catalyzed by adenosine 3':5'-monophosphate- and calmodulin-dependent protein kinases on calcium transport ATPase of cardiac sarcoplasmic reticulum. , 1983, Journal of molecular and cellular cardiology.

[27]  S. Harding,et al.  Sensitization of Human Atrial 5-HT4 Receptors by Chronic β-Blocker Treatment , 1995 .

[28]  H. Sabbah,et al.  Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium. , 2002, Biochemical pharmacology.

[29]  Q. Han,et al.  Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. , 2005, Pharmacology & therapeutics.

[30]  S. Winegrad,et al.  Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Mattiazzi,et al.  Immunodetection of Phosphorylation Sites Gives New Insights into the Mechanisms Underlying Phospholamban Phosphorylation in the Intact Heart* , 1996, The Journal of Biological Chemistry.

[32]  S. Motomura,et al.  Chronic β1‐adrenoceptor antagonist treatment sensitizes β2‐adrenoceptors, but desensitizes M2‐muscarinic receptors in the human right atrium , 1990, British journal of pharmacology.

[33]  P. Karczewski,et al.  Differential sensitivity to isoprenaline of troponin I and phospholamban phosphorylation in isolated rat hearts. , 1990, The Biochemical journal.

[34]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.

[35]  Ernst-GeorgKrause,et al.  Both β2- and β1-Adrenergic Receptors Mediate Hastened Relaxation and Phosphorylation of Phospholamban and Troponin I in Ventricular Myocardium of Fallot Infants, Consistent With Selective Coupling of β2-Adrenergic Receptors to Gs-Protein , 2000 .

[36]  A. Gilman.  A protein binding assay for adenosine 3':5'-cyclic monophosphate. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Schwinger,et al.  Reduced Ca2+-Sensitivity of SERCA 2a in Failing Human Myocardium due to Reduced Serin-16 Phospholamban Phoshorylation , 1999 .

[38]  C. Plumpton,et al.  Selective β1‐adrenoceptor blockade enhances the activity of the stimulatory G‐protein in human atrial myocardium , 1999, British journal of pharmacology.

[39]  W. Schmitz,et al.  INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE , 1988, The Lancet.

[40]  G. Drago,et al.  Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. , 1994, The Journal of biological chemistry.

[41]  K. Fong,et al.  Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. , 2002, Journal of the American College of Cardiology.

[42]  S. Green,et al.  Myocardial signaling defects and impaired cardiac function of a human beta 2-adrenergic receptor polymorphism expressed in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Wallukat,et al.  New insights into beta2-adrenoceptor signaling in the adult rat heart. , 2003, Cardiovascular research.

[44]  W. White,et al.  Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i). , 2000, Circulation research.

[45]  M. Steinfath,et al.  Effects of metoprolol on myocardial beta-adrenoceptors and Gi alpha-proteins in patients with congestive heart failure. , 1996, European journal of clinical pharmacology.

[46]  R. Hetzer,et al.  Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. , 1986, Journal of cardiovascular pharmacology.

[47]  W. Schmitz,et al.  Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. , 1992, Circulation research.

[48]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[49]  M. Petch,et al.  In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment. , 1991, Circulation research.

[50]  P. Karczewski,et al.  The endogenous cardiac sarcoplasmic reticulum Ca2+/calmodulin‐dependent kinase is activated in response to β‐adrenergic stimulation and becomes Ca2+‐independent in intact beating hearts , 1997, FEBS letters.

[51]  R. Schwinger,et al.  Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. , 1999, Journal of molecular and cellular cardiology.

[52]  Ernst-GeorgKrause,et al.  Activation of β2-Adrenergic Receptors Hastens Relaxation and Mediates Phosphorylation of Phospholamban, Troponin I, and C-Protein in Ventricular Myocardium From Patients With Terminal Heart Failure , 1999 .

[53]  P. Molenaar,et al.  Activation of calcineurin in human failing heart ventricle by endothelin‐1, angiotensin II and urotensin II , 2005, British journal of pharmacology.

[54]  M. Petch,et al.  Sensitization by 3-Antagonist Treatment , 1991 .

[55]  L. Sanders,et al.  Chronic β1-adrenoceptor blockade sensitises the H1 and H2 receptor systems in human atrium: role of cyclic nucleotides , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[56]  K. Mittmann,et al.  A common motif of two adjacent phosphoserines in bovine, rabbit and human cardiac troponin I , 1990 .

[57]  M. Maltbie,et al.  The role of potassium and calcium ions in the effect of epinephrine on cardiac cyclic adenosine 3',5'-monophosphate, phosphorylase kinase, and phosphorylase. , 1968, Molecular pharmacology.

[58]  C. Unkel,et al.  Regional expression of phospholamban in the human heart. , 1999, Cardiovascular research.

[59]  P. Molenaar,et al.  Carvedilol blocks h 2 - more than h 1 -adrenoceptors in human heart , 2006 .

[60]  A. Kaumann,et al.  The affinity of (−)-propranolol for β1- and β1-autoreceptors of human heart , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[61]  A. Kaumann,et al.  Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP. , 1991, Naunyn-Schmiedeberg's archives of pharmacology.

[62]  R. Erickson,et al.  Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. , 1997, The Journal of clinical investigation.

[63]  K. Boheler,et al.  Isoprenaline stimulates gene transcription of the inhibitory G protein alpha-subunit Gi alpha-2 in rat heart. , 1993, Circulation research.

[64]  S. Liggett,et al.  Pharmacology and physiology of human adrenergic receptor polymorphisms. , 2003, Annual review of pharmacology and toxicology.

[65]  M. Brown,et al.  A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. , 1989, European heart journal.

[66]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[67]  M. Steinfath,et al.  Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure , 1996, European Journal of Clinical Pharmacology.

[68]  S. Green,et al.  A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. , 1993, The Journal of biological chemistry.

[69]  U. Ravens,et al.  Cilostamide potentiates more the positive inotropic effects of (−)-adrenaline through β2-adrenoceptors than the effects of (−)-noradrenaline through β1-adrenoceptors in human atrial myocardium , 2006, Naunyn-Schmiedeberg's Archives of Pharmacology.

[70]  E. Lakatta,et al.  Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation. , 1994, The Journal of biological chemistry.

[71]  K. Fong,et al.  (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the β1-adrenoceptor , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[72]  T. Eschenhagen,et al.  Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. , 2003, Cardiovascular research.

[73]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[74]  P. Karczewski,et al.  β2-Adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium , 1996, Molecular and Cellular Biochemistry.

[75]  L. Birnbaumer,et al.  Efficacy of beta 1-adrenergic receptors is lower than that of beta 2-adrenergic receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Kaumann,et al.  β2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[77]  E. Kranias,et al.  Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. , 2005, Cardiovascular research.

[78]  E. Lakatta,et al.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.

[79]  A. Kaumann,et al.  Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation. , 1987, Naunyn-Schmiedeberg's archives of pharmacology.

[80]  J. Schulte am Esch,et al.  Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. , 1992, Molecular pharmacology.

[81]  I. Morano.  Tuning the human heart molecular motors by myosin light chains , 1999, Journal of Molecular Medicine.

[82]  P. Insel,et al.  The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. , 2003, Pharmacogenetics.

[83]  S. Jamieson,et al.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. , 1986, Circulation research.

[84]  P. Mateo,et al.  Glycolysis supports calcium uptake by the sarcoplasmic reticulum in skinned ventricular fibres of mice deficient in mitochondrial and cytosolic creatine kinase. , 2000, Journal of molecular and cellular cardiology.

[85]  F. del Monte,et al.  Sensitization of human atrial 5-HT4 receptors by chronic beta-blocker treatment. , 1995, Circulation.

[86]  A. Kaumann,et al.  Regional differences of β1- and β2-adrenoceptor-mediated functions in feline heart , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.